Tag: Brief
Hong Kong – CMAB and HYAB continue to brief association representatives on proposals to improve governance at district level (with photos)
CMAB and HYAB continue to brief association representatives on proposals to improve governance at district level (with photos) ****************************************************************************************** The Secretary for Constitutional and Mainland Affairs, Mr Erick Tsang Kwok-wai, and the Secretary for Home and Youth Affairs, Miss Alice Mak, met with representatives of the Hong Kong Island Federation to explain the proposals on improving governance at the district level today (June 1). Mr Tsang and Miss Mak mentioned that the proposals could institutionally prevent ineffectiveness of district administration, ensuring that the District Councils (DCs) will operate in compliance with provisions of the Basic Law ... Read more
Hong Kong – CMAB and HYAB continue to brief political parties on proposals to improve governance at district level (with photos)
CMAB and HYAB continue to brief political parties on proposals to improve governance at district level (with photos) ****************************************************************************************** After the Government’s announcement of the proposals on improving governance at the district level on May 2, the Secretary for Constitutional and Mainland Affairs, Mr Erick Tsang Kwok-wai, and the Secretary for Home and Youth Affairs, Miss Alice Mak, immediately commenced explanatory and publicity work for various sectors. The two Directors of Bureaux began to meet different political parties yesterday. They hosted briefing sessions today (May 9) for representatives of the Business and Professionals Alliance for Hong Kong and the ... Read more
FDA In Brief: FDA Finalizes Guidance with Internationally Harmonized Recommendations to Further Support Safe, High-Quality Human Drug Products
The FDA is continually working to promote drug innovation and improvement, strengthen quality assurance, safety and supply of drug products and enable more efficient use of industry and regulatory resources. Through the harmonization of requirements for drug lifecycle management, manufacturers and the FDA can meet these goals in less time through effective management of postapproval changes. To help provide a more predictable and efficient approach to management of postapproval changes, today were announcing a final guidance for industry with new International Council for Harmonisation (ICH) guidelines. Effective implementation of this guidance will provide an opportunity for the FDA to focus ... Read more